PKM and colorectal carcinoma: The lncRNA LiNC01852 modulates the TRIM72/SRSF5/PKM2 signaling axis, indirectly downregulating PKM2 expression through a multi-stage regulatory mechanism, thereby suppressing CRC cell proliferation and chemoresistance (91).